Europe Artificial Organs and Bionic Implants Market Size (2024 - 2029)

Europe Artificial Organs & Bionic Implants Market Analysis

The Europe Artificial Organs and Bionic Implants Market size is estimated at USD 8.65 billion in 2024, and is expected to reach USD 12.35 billion by 2029, growing at a CAGR of 7.35% during the forecast period (2024-2029).

The onset of COVID-19 had a significant impact on the market studied. The number of transplants dropped in Europe during the initial phase of the pandemic. The decrease was certainly due to the risk of infection through the allograft, a significant increase in SARS-CoV-2-related morbidity and mortality in immunocompromised hosts. Kidney transplant and live donor programs were particularly affected, with significant negative spillover consequences for patients on the waiting list. According to a research study published in the Pathogens Journal in September 2022, higher mortality was seen during the pandemic among the transplant waiting list (TWL) patients compared to pre-COVID-19 TWL patients in Europe. It shows that there was a delay in transplantation procedures which further impacted the demand for artificial organs and bionics in the region. Hence, the market was affected adversely. However, the high burden of kidney diseases and cardiovascular diseases across Europe during the later phases of the pandemic created a demand for organ transplantations. This created opportunities for artificial organs and bionics and accelerated the market's growth in Europe. Hence, it is expected that the market will witness considerable growth over the analysis period.

Factors such as the rising incidence of organ failures, high Increased incidence of disabilities, scarcity of donor organs, and technological advancements leading to enhanced applications are anticipated to drive market growth over the forecast period.

Kidneys, the liver, lungs, the heart, the central nervous system, and the hematologic system are the major organs that tend to fail among the target population. In Europe, the number of organ failures has been increasing consistently over the few decades, but the number of organ donors is a few. This is creating demand for artificial organs in the region. As per a study published in the Nature Reviews Nephrology Journal in May 2021, changes in demographics and the burden of non-communicable diseases (NCDs) that are responsible for 77% of the disease burden in Europe were major components that increased the chance for organ transplantation in the region.

In addition, as per the European Committee on Organ Transplantation survey results published in September 2022, last year, kidney transplant was the most performed transplant in the European Union and accounted for 15,700 procedures, followed by 6,500 liver transplants and 2,000 heart transplants. This high number of transplants is anticipated to create opportunities for artificial organs and the bionics market in the region. Thus, this is anticipated to contribute to the global artificial organs and bionics implants market growth over the forecast period.

However, expensive procedures and fear of device malfunction and its consequences are expected to hinder the market's growth.

Europe Artificial Organs & Bionic Implants Industry Segmentation

As per the scope of the report, artificial organs are mechanical devices that can temporarily or permanently substitute for a body organ. These devices can replicate or augment the natural function of the organ. Bionics refers to the replacement or improvement of body parts by mechanical kinds. 

The European Artificial Organs and Bionic Implants Market is Segmented by Type (Artificial Organs and Bionics) and Geography (Germany, United Kingdom, France, Italy, Spain, and the Rest of Europe). The report offers the value (in USD million) for the above segments.